T cell receptor signaling has been reported to play a role in the progression of extranodal NK/T cell lymphoma and to activate the ITK/NF-κB/GATA-3 axis to promote chemoresistance in T cell lymphomas [37, 38]. Here, ITK is linked to T-cell non-Hodgkin lymphoma.